Literature DB >> 11348457

Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase.

P L Zeeuwen1, I M Van Vlijmen-Willems, B J Jansen, G Sotiropoulou, J H Curfs, J F Meis, J J Janssen, F Van Ruissen, J Schalkwijk.   

Abstract

Using serial analysis of gene expression on cultured human keratinocytes we found high expression levels of genes putatively involved in host protection and defense, such as proteinase inhibitors and antimicrobial proteins. One of these expressed genes was the recently discovered cysteine proteinase inhibitor cystatin M/E that has not been characterized so far at the protein level with respect to tissue distribution and additional biologic properties. Here we report that cystatin M/E has a tissue-specific expression pattern in which high expression levels are restricted to the stratum granulosum of normal human skin, the stratum granulosum/spinosum of psoriatic skin, and the secretory coils of eccrine sweat glands. Low expression levels were found in the nasal cavity. The presence of cystatin M/E in skin and the lack of expression in a variety of other tissues was verified both at the protein level by immunohistochemistry or western blotting, and at the mRNA level by reverse transcriptase polymerase chain reaction or northern blotting. Using biotinylated hexapeptide probes we found that cystatin M/E is an efficient substrate for tissue type transglutaminase and for transglutaminases extracted from stratum corneum, and that it acts as an acyl acceptor but not as an acyl donor. Western blot analysis showed that recombinant cystatin M/E could be cross-linked to a variety of proteins extracted from stratum corneum. In vitro, we found that cystatin M/E expression in cultured keratinocytes is upregulated at the mRNA and protein level, upon induction of differentiation. We demonstrate that cystatin M/E, which has a putative signal peptide, is indeed a secreted protein and is found in vitro in culture supernatant and in vivo in human sweat by enzyme-linked immunosorbent assay or western blotting. Cystatin M/E showed moderate inhibition of cathepsin B but was not active against cathepsin C. We speculate that cystatin M/E is unlikely to be a physiologically relevant inhibitor of intracellular lysosomal cysteine proteinases but rather functions as an inhibitor of self and nonself cysteine proteinases that remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348457     DOI: 10.1046/j.1523-1747.2001.01309.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays.

Authors:  Angela Sesto; Manuel Navarro; Frank Burslem; José L Jorcano
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.

Authors:  Marijke Kamsteeg; Mieke Bergers; Roelie de Boer; Patrick L J M Zeeuwen; Stanleyson V Hato; Joost Schalkwijk; Geuranne S Tjabringa
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.

Authors:  Hanna Wallin; Jenny Apelqvist; Freddi Andersson; Ulf Ekström; Magnus Abrahamson
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

4.  Development and validation of human psoriatic skin equivalents.

Authors:  Geuranne Tjabringa; Mieke Bergers; Desiree van Rens; Roelie de Boer; Evert Lamme; Joost Schalkwijk
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

5.  Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.

Authors:  Kévin Baranger; Marie-Louise Zani; Valérie Labas; Sandrine Dallet-Choisy; Thierry Moreau
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

6.  Internalization of exogenous cystatin F supresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms.

Authors:  Jeff D Colbert; Stephen P Matthews; Janko Kos; Colin Watts
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

7.  Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.

Authors:  Jenny S Breitenbach; Mark Rinnerthaler; Andrea Trost; Manuela Weber; Alfred Klausegger; Christina Gruber; Daniela Bruckner; Herbert A Reitsamer; Johann W Bauer; Michael Breitenbach
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

Review 8.  Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris.

Authors:  Marta Stawczyk-Macieja; Aneta Szczerkowska-Dobosz; Krzysztof Rębała; Dorota Purzycka-Bohdan
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

9.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

10.  Serial Analysis of Gene Expression: Applications in Human Studies.

Authors:  Renu Tuteja; Narendra Tuteja
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.